A detailed history of Lmr Partners LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 14,995 shares of MRK stock, worth $1.49 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,995
Holding current value
$1.49 Million
% of portfolio
0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $1.67 Million - $1.93 Million
14,995 New
14,995 $1.7 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $1.05 Million - $1.22 Million
9,278 New
9,278 $1.22 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $2.89 Million - $3.71 Million
-33,051 Reduced 71.43%
13,217 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $3.91 Million - $4.39 Million
46,268 New
46,268 $3.99 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $228,064 - $268,636
-3,312 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $871,933 - $967,667
-12,149 Reduced 78.58%
3,312 $271,000
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $1.13 Million - $1.28 Million
15,461 New
15,461 $1.28 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $1.94 Million - $2.12 Million
-25,532 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $1.78 Million - $2.08 Million
25,532 New
25,532 $2.14 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $2.07 Million - $2.36 Million
-29,793 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $1.94 Million - $2.26 Million
29,793 New
29,793 $2.28 Million
Q4 2017

Jan 30, 2018

SELL
$51.62 - $61.64 $386,375 - $461,375
-7,485 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $439,144 - $472,528
7,485
7,485 $480,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.